Evidence map›Paper›PMID 25316714›Full record

ArticleJournal of diabetes science and technology2015

Evaluating quality of glycemic control: graphical displays of hypo- and hyperglycemia, time in target range, and mean glucose.

David Rodbard

Open access · bronzeAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of diabetes science and technology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Diabetes Technology Meeting 2020.Journal of diabetes science and technology · 2021
    Article
  8. Review
  9. Article
  10. Review
  11. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.Journal of diabetes science and technology · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Glucose variability, HbA1c and microvascular complications.Reviews in endocrine & metabolic disorders · 2016
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David RodbardBiomedical Informatics Consultants LLC, Potomac, MD, USA drodbard@comcast.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is need for readily understandable graphical displays of glucose data to facilitate interpretation by clinicians and researchers. (1) Display of the percentage of glucose values above a specified threshold for hyperglycemia (%High) versus percentage of glucose values below a specified threshold for hypoglycemia (%Low). If all glucose values fell within the target range, then all data points would fall at the origin. (2) After an intervention, one can plot the change in percentage of glucose values above a specified threshold for hyperglycemia versus the change in percentage of glucose values below a specified threshold defining hypoglycemia: The quadrants of this graph correspond to (a) increased risk of both hyper- and hypoglycemia, (b) decreased hyperglycemia but increased risk of hypoglycemia, (c) decreases in both hypo- and hyperglycemia, and (d) decreased hypoglycemia but increased hyperglycemia. (3) A 2-dimensional triangular graph can be used for simultaneous display of %High, %Low, and percentage in target range. (4) Display of risk of hyper- versus risk of hypoglycemia based on both frequency and severity of departures from the target range can be used. (5) Graphs (1) and (4) can also be presented using percentile scores relative to a reference population. (6) It is also useful to analyze %Hypoglycemia or risk of hypoglycemia versus mean glucose. These methods are illustrated with examples from representative cases and shown to be feasible, practical, and informative. These new types of graphical displays can facilitate rapid analysis of risks of hypo- and hypoglycemia simultaneously and responses to therapeutic interventions for individuals or in clinical trials.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringComputer GraphicsData AccuracyData DisplayData Interpretation, StatisticalDiabetes Mellitus, Type 1HumansHyperglycemiaHypoglycemiaPredictive Value of TestsQuality ControlTime FactorsBlood Glucosecontinuous glucose monitoringdiabetes mellitusglycemic controlhyperglycemiahypoglycemiaself-monitoring of blood glucose

Identifiers

PMID25316714
PMCPMC4495532
OpenAlexW2113764001

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.